生命科学资讯

Unified modeling of 3D molecular generation via atomic interactions with PocketXMol

A circadian rheostat drives proton electrochemical gradients to optimize cell-type-specific growth in Arabidopsis

Brain-wide mapping of oligodendrocyte organization, oligodendrogenesis, and myelin injury

Tuning the sensitivity of mechanosensory receptors through histidine scanning

Liver exerkine reverses aging- and Alzheimer’s-related memory loss via vasculature

Sanofi backs Altesa's $75M series B to bankroll antiviral's midstage rhinovirus study

Study finds blood test can predict age of Alzheimer's onset

J&J halts enrollment in phase 2 trial of AC Immune-partnered Alzheimer's therapy

Biogen stops part of an MS trial; Merck reports more Enflonsia data

Sanofi to expand in India; Stada invests $100M in Saudi Arabia

Is Thermo Fisher’s Datavant Deal and Clario Financing Altering The Investment Case For TMO? - simplywall.st

Hims to buy Australia’s Eucalyptus for $240M upfront in global push

Lonza Strengthens Advanced Synthesis Offering - Contract Pharma

Waters launches 1 mm microflow LC columns to boost sensitivity, cut solvents - Chromatography Today

Ontario Teachers Pension Plan Board Purchases New Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat

Is It Time To Reassess Illumina (ILMN) After Recent Share Price Volatility - Yahoo Finance

Will vaccine regulatory uncertainty chill innovation? Pharma execs sound off.

East China Normal University synthesizes adenosine receptor antagonists

CLK and/or DYRK inhibitors disclosed in Tarapeutics Science patent

Onco3r Therapeutics discovers FGFR3 inhibitors